To help enterprises stay updated with the policy developments, optimize compliance strategies, and successfully expand into the US market, CIRS is to host a free webinar on April 8, 2025 at 15:30 (GMT). We will focus on the latest U.S. cosmetic regulations, key changes, critical procedures for cosmetic and OTC product entry into the U.S. market, and the FDA regulatory priorities. This webinar is also available in Chinese, Japanese, and Korean.

This article compiles and summarizes the latest updates on cosmetics regulations in China and globally as of February 2025, covering newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

On March 17, 2025, the National Institutes for Food and Drug Control (NIFDC) released a FAQ document on technical review of cosmetics related to new cosmetic ingredients. We have collected the latest FAQs and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

On February 11, 2025, the United States notified a cosmetic-related measure (G/TBT/N/USA/2187) restricting the intentional addition of formaldehyde and formaldehyde releasers in cosmetics. The deadline for public comments is April 11, 2025. If approved, the restriction will take effect on January 1, 2027.

This article compiles data on cosmetic sampling inspections conducted within China and updates related information for February 2025.

On March 5, 2025, CIRS Group once again successfully assisted clients in securing new cosmetic ingredient registration numbers. According to the database of China's National Medical Products Administration (NMPA), the newly registered ingredient is HDI/Di-C12-14 Alkyl Tartrate/Hydrogenated Dimer Dilinoleyl Copolymer (Registration No.: Guo Zhuang Yuan Bei Zi 20250021), with Intercos S.p.A. listed as the registrant. To date, a total of 22 new cosmetic ingredients have been registered in 2025, with CIRS Group providing technical support for more than one-fourth of these registrations.

CIRS Group is to host a free webinar regarding summary of 2024 China cosmetic regulatory requirements respectively on February 20, March 6, and March 7. In this webinar, we will provide an in-depth analysis of cosmetics registration and filing updates in 2024, the latest regulatory changes and key points, as well as efficacy testing requirements and relevant case studies under China’s cosmetic regulations, aiming to help enterprises stay informed about policy trends and optimize their compliance strategies.

To foster innovation in cosmetic ingredients and advance the high-quality growth of the cosmetic industry, the National Medical Products Administration (NMPA) of China has developed the Provisions for Supporting Innovation in Cosmetic Ingredients (No. 12 of 2025). These provisions, formulated in line with the Cosmetics Supervision and Administration Regulations and other pertinent laws and regulations, were officially issued and took effect on February 6, 2025.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.